Our identification of GSX1+ clusters in high-grade IDH-mutant astrocytoma aligns with its broader role in fate determination and malignancy, suggesting conserved mechanisms whereby GSX1 may drive aggressive phenotypes through aberrant differentiation or synaptic signaling pathways. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).